FDA
approval
· 2021-01-04
FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
Summary
FDA approved a supplemental application for Bupropion Hydrochloride from Amneal Pharmaceuticals of New York LLC, authorizing the generic product for marketing.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)